Kumari Wickramasinghe

1.8k total citations
18 papers, 1.3k citations indexed

About

Kumari Wickramasinghe is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Kumari Wickramasinghe has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Kumari Wickramasinghe's work include Esophageal Cancer Research and Treatment (13 papers), Esophageal and GI Pathology (5 papers) and Gastric Cancer Management and Outcomes (4 papers). Kumari Wickramasinghe is often cited by papers focused on Esophageal Cancer Research and Treatment (13 papers), Esophageal and GI Pathology (5 papers) and Gastric Cancer Management and Outcomes (4 papers). Kumari Wickramasinghe collaborates with scholars based in United States, Germany and Australia. Kumari Wickramasinghe's co-authors include Tom R. DeMeester, Reginald V. Lord, Jeffrey H. Peters, Steven R. DeMeester, Kristin A. Skinner, Tiffany I. Long, Cindy A. Eads, Peter V. Danenberg, Kathleen D. Danenberg and Yanling Ma and has published in prestigious journals such as Gastroenterology, Oncogene and Journal of the American Society of Nephrology.

In The Last Decade

Kumari Wickramasinghe

16 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kumari Wickramasinghe United States 13 777 656 352 166 164 18 1.3k
Daniela Graziani Italy 11 284 0.4× 248 0.4× 163 0.5× 107 0.6× 393 2.4× 23 767
Tom Smyrk United States 16 323 0.4× 369 0.6× 104 0.3× 466 2.8× 565 3.4× 17 1.3k
Steffen Pistorius Germany 14 150 0.2× 186 0.3× 117 0.3× 163 1.0× 331 2.0× 32 666
Nils Glenjen Norway 13 179 0.2× 404 0.6× 437 1.2× 128 0.8× 189 1.2× 22 838
B Neubauer Germany 9 105 0.1× 462 0.7× 354 1.0× 40 0.2× 149 0.9× 12 832
Frank Schönleben Germany 16 351 0.5× 360 0.5× 242 0.7× 176 1.1× 505 3.1× 22 878
Anna Felisiak-Gołąbek Poland 14 156 0.2× 96 0.1× 206 0.6× 90 0.5× 200 1.2× 20 544
Shuichiro Uchiyama Japan 13 144 0.2× 305 0.5× 98 0.3× 50 0.3× 151 0.9× 43 601
Donia McLemore United States 13 171 0.2× 155 0.2× 283 0.8× 154 0.9× 178 1.1× 19 547
Jan‐Willem R. Mulder Netherlands 7 219 0.3× 270 0.4× 131 0.4× 108 0.7× 479 2.9× 8 796

Countries citing papers authored by Kumari Wickramasinghe

Since Specialization
Citations

This map shows the geographic impact of Kumari Wickramasinghe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kumari Wickramasinghe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kumari Wickramasinghe more than expected).

Fields of papers citing papers by Kumari Wickramasinghe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kumari Wickramasinghe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kumari Wickramasinghe. The network helps show where Kumari Wickramasinghe may publish in the future.

Co-authorship network of co-authors of Kumari Wickramasinghe

This figure shows the co-authorship network connecting the top 25 collaborators of Kumari Wickramasinghe. A scholar is included among the top collaborators of Kumari Wickramasinghe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kumari Wickramasinghe. Kumari Wickramasinghe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wickramasinghe, Kumari, et al.. (2024). Tocilizumab in the Treatment of Allograft Rejection in an HIV-Positive Kidney Transplant Recipient. Journal of the American Society of Nephrology. 35(10S).
2.
Wickramasinghe, Kumari, et al.. (2009). Agent-based intelligent collaborative care management. RMIT Research Repository (RMIT University Library). 1387–1388. 3 indexed citations
3.
Chandrasoma, Parakrama, Kumari Wickramasinghe, Yanling Ma, & Tom R. DeMeester. (2007). Adenocarcinomas of the Distal Esophagus and “Gastric Cardia” Are Predominantly Esophageal Carcinomas. The American Journal of Surgical Pathology. 31(4). 569–575. 55 indexed citations
4.
Chandrasoma, Para, Kumari Wickramasinghe, Yanling Ma, & Tom R. DeMeester. (2007). Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia?. Diseases of the Esophagus. 20(1). 36–41. 51 indexed citations
5.
6.
Chandrasoma, Parakrama, et al.. (2005). A proposal for a new validated histological definition of the gastroesophageal junction. Human Pathology. 37(1). 40–47. 56 indexed citations
7.
Lord, Reginald V., Jan Brabender, Kumari Wickramasinghe, et al.. (2005). Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma. Surgery. 138(5). 924–931. 60 indexed citations
8.
Lord, Reginald V., et al.. (2004). Cardiac mucosa in the remnant esophagus after esophagectomy is an acquired epithelium with Barrett's-like features. Surgery. 136(3). 633–640. 52 indexed citations
9.
DeMeester, Steven R., et al.. (2003). Etiology of intestinal metaplasia at the gastroesophageal junction. Surgical Endoscopy. 17(1). 43–48. 21 indexed citations
10.
Lord, Reginald V., Ji Min Park, Kumari Wickramasinghe, et al.. (2003). Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus. Journal of Thoracic and Cardiovascular Surgery. 125(2). 246–253. 59 indexed citations
11.
DeMeester, Steven R., Kumari Wickramasinghe, Reginald V. Lord, et al.. (2002). Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus. The American Journal of Gastroenterology. 97(10). 2514–2523. 68 indexed citations
12.
Brabender, Jan, Reginald V. Lord, Kumari Wickramasinghe, et al.. (2002). Glutathione S–Transferase-Pi Expression Is Downregulated in Patients With Barrett's Esophagus and Esophageal Adenocarcinoma. Journal of Gastrointestinal Surgery. 6(3). 359–367. 41 indexed citations
13.
Brabender, Jan, Henning Usadel, Kathleen D. Danenberg, et al.. (2001). Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene. 20(27). 3528–3532. 113 indexed citations
14.
Chandrasoma, Parakrama & Kumari Wickramasinghe. (2001). Pathology of Gastroesophageal Reflux Disease and Barrett???s Esophagus. 18(2). 43–52. 2 indexed citations
15.
Wajed, Saj, Tiffany I. Long, Cindy A. Eads, et al.. (2001). DNA methylation patterns predict clinical outcome in esophageal adenocarcinoma. Gastroenterology. 120(5). A31–A31.
16.
Eads, Cindy A., Reginald V. Lord, Kumari Wickramasinghe, et al.. (2001). Epigenetic patterns in the progression of esophageal adenocarcinoma.. PubMed. 61(8). 3410–8. 434 indexed citations
17.
Wickramasinghe, Kumari, et al.. (2000). The immunohistochemical similarity of cardiac mucosa, intestinal metaplasia of the cardia, and barrett's esophagus. Gastroenterology. 118(4). A1030–A1030. 3 indexed citations
18.
Eads, Cindy A., Reginald V. Lord, Kumari Wickramasinghe, et al.. (2000). Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma.. PubMed. 60(18). 5021–6. 306 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela Graziani Breakdown of academic impact, for papers by Tom Smyrk Breakdown of academic impact, for papers by Steffen Pistorius Breakdown of academic impact, for papers by Nils Glenjen Breakdown of academic impact, for papers by B Neubauer Breakdown of academic impact, for papers by Frank Schönleben Breakdown of academic impact, for papers by Anna Felisiak-Gołąbek Breakdown of academic impact, for papers by Shuichiro Uchiyama Breakdown of academic impact, for papers by Donia McLemore Breakdown of academic impact, for papers by Jan‐Willem R. Mulder
Rankless by CCL
2026